TZP-102 Uses, Dosage, Side Effects and more

TZP-102 is under investigation in clinical trial NCT01452815 (Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis).

Trade Name TZP-102
Generic TZP-102
Type
Formula C28H44N4O4
Weight Average: 500.684
Monoisotopic: 500.336255913
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share